Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
Dementia Linked to Deficient DNA Repair
Mutant forms of breast cancer factor 1 (BRCA1) are associated with breast and ovarian cancers but according to new findings, in the brain the normal BRCA1 gene product may also be linked to Alzheimer’s disease.
Using Drug-Susceptible Parasites to Fight Drug Resistance
Researchers at the University of Georgia have developed a model for evaluating a potential new strategy in the fight against drug-resistant diseases.
Boosting Breast Cancer Treatment
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
New Discovery Sheds Light on Disease Risk
Gaps between genes interact to influence the risk of acquiring disease.
How Cells ‘Climb’ to Build Fruit Fly Tracheas
Mipp1 protein helps cells sprout “fingers” for gripping.
Research Finding Could Lead to Targeted Therapies for IBD
Findings published online in Cell Reports.
Scroll Up
Scroll Down

High Throughput GWAS Analysis
Bookmark and Share

InforSense Limited

Genome Wide Association Studies, or GWAS for short, are gradually becoming more commonplace. The main goals of these studies are to find genetic variants, or SNPs, that are correlated between Case or Control individuals. There have been recent publications announcing successful results in this field, including some of the first results from consortia who are currently running some of the largest GWA studies.

Current challenges for dealing with the GWA data include:

- How to handle and process large data sets.
- How to flexibly assess the quality of the data that is generated.
- How to cope with an area whose analysis methods are continually evolving.
- How to bring in context from other areas.
- How to build flexible analyses and comparing different statistical methods.
- How to integrate scripts and 3rd party tools in a maintainable environment.

In this paper we’ll briefly describe how InforSense has met some of these challenges
which scientists have to solve when faced with analysing the results from a GWA study.

Further Information

Related Content

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease
Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
Wednesday, December 03, 2008
InforSense GenSense Achieves GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
Affymetrix has become a member of InforSense’s Open Workflow Partner Network joining over 40 other partners in the program.
Tuesday, August 07, 2007
InforSense® Announces Conference Series
The InforSense Users Conference will provide opportunity to learn how InforSense KDE is being used to facilitate business-critical decision-making across a variety of industries.
Tuesday, November 14, 2006
$10 Million Investment to Boost InforSense Expansion
Fleming Family & Partners Private Equity and Imperial Innovations lead strategic investment round.
Tuesday, October 10, 2006
EU-Funded ARGUGRID Project Adopts InforSense® Integrative Analytics Technology
InforSense to provide integrative analytics environment to support collaborative decision making.
Wednesday, October 04, 2006
InforSense® Appoints David Hadfield as Chief Operating Officer
Former Spotfire executive strengthens InforSense management team.
Tuesday, October 03, 2006
Bayer Selects InforSense for Next Generation Integrative Analytics Infrastructure
InforSense KDE, will provide Bayer with a flexible rapid application development platform to optimize their drug discovery decision-making.
Friday, September 16, 2005
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos